Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0JR5G
|
|||
| Drug Name |
PMID26924192-Compound-50
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
INCYTE CORPORATIOIncyte Corporation
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H17N3O3
|
|||
| Canonical SMILES |
CN1C=C(C2=C(C1=O)NC=C2)C3=C4C(=CC=C3)NC(=O)C(O4)C5=CC=CC=C5
|
|||
| InChI |
1S/C22H17N3O3/c1-25-12-16(14-10-11-23-18(14)22(25)27)15-8-5-9-17-20(15)28-19(21(26)24-17)13-6-3-2-4-7-13/h2-12,19,23H,1H3,(H,24,26)
|
|||
| InChIKey |
DWZVOOLKEMMANA-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bromodomain and extraterminal domain protein (BET) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Bromodomain and extraterminal domain protein (BET) | Target's Patent Info | [1] | |
| KEGG Pathway | SNARE interactions in vesicular transport | |||
| Reactome | COPII (Coat Protein 2) Mediated Vesicle Transport | |||
| WikiPathways | miR-targeted genes in squamous cell - TarBase | |||
| miR-targeted genes in muscle cell - TarBase | ||||
| miR-targeted genes in lymphocytes - TarBase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.